Isorg raises €24m to advance printed large-area image sensor development

Share this on social media:

French company Isorg, which specialises in printed organic photodetectors and large-area image sensors, has raised €24 million in a Series B financing round.

Isorg’s technology is based on organic-conductor and semiconductor materials combined with large area, high-volume deposition and patterning equipment. It is able to print large-area image sensors on plastic and glass by depositing organic photosensitive layers on top of a transistor matrix backplane.

Its large-area image sensors – 32 x 38cm – can operate in the visible and near infrared. The pixel pitch is 84µm or 50µm.

The technology primarily addresses applications in personal electronic devices such as smartphones, wearables, tablets and laptops, biometrics for homeland security, and medical imaging.

The €24 million funding will be used to support the different qualification steps of its production site based in Limoges, and continue the development of subsystems ready to be integrated in the various applications. It will support the engineering work to enable large-scale commercialisation.

New Science Ventures (NSV), a US-based investment firm, and Bpifrance, through its fund Large Venture, are leading the round alongside Financière Fonds Privés (FFP) and current investors, Sofimac Innovation, CEA Investissement and Dynalim.

‘We are heading towards launching the large-scale commercialisation of our image sensors and other printed electronics solutions, which are in high demand among manufacturers of consumer electronics and biometric devices,’ commented Jean-Yves Gomez, CEO and co-founder of Isorg.

Related news

12 February 2021

Cognex's revenue was $811m for the year, a 12 per cent year-on-year increase thanks to higher revenue from consumer electronics and e-commerce

Six images at relevant wavelengths to differentiate tumour cells. Credit: CEA-Leti

18 March 2021

CEA-Leti scientists have developed a lensless, infrared spectral imaging system for medical diagnostics. It plans to commercialise the technology through a start-up